Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
This Focus on neuroinflammation highlights the importance of the field across neurological subspecialties, and has been developed in collaboration with the European Academy of Neurology (EAN) to include articles written by experts who spoke at the 5th EAN Congress on the overarching theme of neuroinflammation.
The Key Advances in Medicine 2019 collection, a collaborative effort from the eight clinical Nature Reviews journals, offers expert insight into the most important discoveries made in 2018, and is an essential resource for students, physicians and clinical researchers.
The first disease-modifying therapy for relapsing–remitting multiple sclerosis — interferon‑β 1b — was approved by the FDA in 1993. The following 25 years have seen rapid expansion of the therapeutic options as an evolving understanding of the disease has enabled development of therapies with different modes of action.
Autoimmunity is an underlying cause of many diseases. This collection of Research, Reviews and News articles from several Nature journals covers the latest advances in genetic and epigenetic research into autoimmunity and autoimmune diseases.
To mark the reclassification of stroke as a neurological disease in the new International Classification of Disease, this collection brings you a selection of articles that address some of the latest and most exciting advances in stroke, including Reviews and commentaries written by world-leading stroke neurologists.
Much like our oceans, the world of clinical and biomedical research is vast, fast-paced, dynamic and full of unanswered questions. In 2017, numerous advances were made that could change the tide of efforts to fight disease. The Key Advances in Medicine eBook distils the major discoveries made in 2017 and highlights trends to look out for in 2018.
2017 marks the 200th anniversary since James Parkinson published his Essay on the Shaking Palsy. To mark this event, Nature Reviews bring together a collection of cutting edge articles that summarize the current basic and clinical research in Parkinson disease.
Beginning in the December 2016 issue, Nature Reviews Neurology will be publishing a series of articles looking at recent advances in our understanding of disease mechanisms, and in the diagnosis and management of a variety of peripheral neuropathies.
Collectively, rare diseases account for a substantial proportion of the worldwide burden of neurological disease, despite their individual low prevalence. The articles in this series highlight the challenges of studying and treating rare neurological diseases, emphasizing the importance of international and multidisciplinary collaboration to foster interactions between patients, clinicians, researchers and advocacy groups.
The past 10 years has seen great advances in the understanding and treatment of human disease. For expert perspectives on the most important breakthroughs, don't miss the FREE A Decade in Medicine eBook. In this special collection of 47 articles, leading experts highlight the most important advances in eight medical specialties between 2004 and 2015, and comment on future developments in their fields.